Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $709,302 (100.0% shares, 0.0% debt)

Holdings (17)

AXSM AXSOME THERAPEUTICS INC 23.8%

Value ($000) $168,510 Shares 2,344,980 Est. Cost $49.79 Unrealized +48.2%

NUVL NUVALENT INC 17.1%

Value ($000) $121,639 Shares 2,884,492 Est. Cost $22.67 Unrealized +66.8%

— IMMUNOGEN INC 16.0%

Value ($000) $113,778 Shares 6,029,592 Est. Cost $18.87 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 6.1%

Value ($000) $43,364 Shares 2,124,625 Est. Cost $20.33 Unrealized -0.6%

COGT COGENT BIOSCIENCES INC 5.9%

Value ($000) $42,138 Shares 3,558,975 Est. Cost $9.69 Unrealized +18.4%

— MERUS N V 5.5%

Value ($000) $39,032 Shares 1,482,405 Est. Cost $24.33 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 4.6%

Value ($000) $32,583 Shares 1,369,623 Est. Cost $15.80 Unrealized +62.4%

ARGX ARGENX SE 4.0%

Value ($000) $28,655 Shares 73,526 Est. Cost $266.01 Unrealized —

TYRA TYRA BIOSCIENCES INC 3.4%

Value ($000) $24,131 Shares 1,416,998 Est. Cost $14.88 Unrealized -2.5%

TERN TERNS PHARMACEUTICALS INC 2.5%

Value ($000) $17,850 Shares 2,040,000 Est. Cost $3.72 Unrealized +213.7%

— ASTRIA THERAPEUTICS INC 2.2%

Value ($000) $15,839 Shares 1,901,397 Est. Cost $11.99 Unrealized —

KOD KODIAK SCIENCES INC 1.9%

Value ($000) $13,698 Shares 1,985,245 Est. Cost $6.12 Unrealized 0.0%

— DBV TECHNOLOGIES SA 1.9%

Value ($000) $13,423 Shares 7,064,964 Est. Cost $2.30 Unrealized —

TRVI TREVI THERAPEUTICS INC 1.7%

Value ($000) $12,405 Shares 5,190,360 Est. Cost $3.04 Unrealized -17.2%

— KINIKSA PHARMACEUTICALS LTD 1.4%

Value ($000) $9,919 Shares 704,459 Est. Cost $14.08 Unrealized —

— VERONA PHARMA PLC 1.1%

Value ($000) $8,074 Shares 381,939 Est. Cost $10.63 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.6%

Value ($000) $4,262 Shares 9,460,540 Est. Cost $0.45 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,344,980	$168,510	23.8%	$49.79	+48.2%	COM	05464T104
NUVL	NUVALENT INC	2,884,492	$121,639	17.1%	$22.67	+66.8%	COM	670703107
—	IMMUNOGEN INC	6,029,592	$113,778	16.0%	$18.87	—	COM	45253H101
ELVN	ENLIVEN THERAPEUTICS INC	2,124,625	$43,364	6.1%	$20.33	-0.6%	COM	29337E102
COGT	COGENT BIOSCIENCES INC	3,558,975	$42,138	5.9%	$9.69	+18.4%	COM	19240Q201
—	MERUS N V	1,482,405	$39,032	5.5%	$24.33	—	COM	N5749R100
VRDN	VIRIDIAN THERAPEUTICS INC	1,369,623	$32,583	4.6%	$15.80	+62.4%	COM	92790C104
ARGX	ARGENX SE	73,526	$28,655	4.0%	$266.01	—	SPONSORED ADR	04016X101
TYRA	TYRA BIOSCIENCES INC	1,416,998	$24,131	3.4%	$14.88	-2.5%	COM	90240B106
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$17,850	2.5%	$3.72	+213.7%	COM	880881107
—	ASTRIA THERAPEUTICS INC	1,901,397	$15,839	2.2%	$11.99	—	COM	04635X102
KOD	KODIAK SCIENCES INC	1,985,245	$13,698	1.9%	$6.12	0.0%	COM	50015M109
—	DBV TECHNOLOGIES SA	7,064,964	$13,423	1.9%	$2.30	—	SPONSORED ADR	23306J101
TRVI	TREVI THERAPEUTICS INC	5,190,360	$12,405	1.7%	$3.04	-17.2%	COM	89532M101
—	KINIKSA PHARMACEUTICALS LTD	704,459	$9,919	1.4%	$14.08	—	COM CL A	G5269C101
—	VERONA PHARMA PLC	381,939	$8,074	1.1%	$10.63	—	SPONSORED ADS	925050106
—	AEGLEA BIOTHERAPEUTICS INC	9,460,540	$4,262	0.6%	$0.45	—	COM	00773J103